UNSPSC 51401502: Climazolam

This classification denotes a benzodiazepine with the molecular formula C18H13Cl2N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O9KZB9HG1Y, chemically known as 8-chloro-6-(o-chlorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine but generally known as climazolam, which bears US NIH Compound Identifier 68790. European Medicines Agency schedules Climazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06661MIG.

UNSPSC 51401502 Climazolam is a Commodity code with little relevant recent activity under its stated scope. The three recent opportunities posted against this code involve naloxone and drug deactivation systems, a direct-to-manufacturer pharmacy initiative, and generic multi-source pharmaceuticals and OTC products — none of which are climazolam, a benzodiazepine pharmaceutical. The mismatch suggests the code may be misapplied in state and local procurement systems or that climazolam procurement through these jurisdictions is not currently occurring at measurable volume. State and local health departments, county health agencies, and pharmacy benefit programs theoretically use this code for controlled-substance pharmaceuticals, but recent solicitation data does not reflect active demand for climazolam specifically.

Geographic activity relating to the code's nominal scope is limited to the records shown: Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023), Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescriptions, posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon (RFP for generic pharmaceuticals and OTC products, due March 26, 2026). These opportunities involve pharmacy procurement, but none target climazolam. Business development professionals should clarify whether climazolam has legitimate state and local procurement volume or whether the code assignment reflects data-quality issues rather than active market opportunity.